クイック注文

BTLA/CD272  タンパク質

All BTLA Reagents

発現宿主: Human Cells  
11895-H02H-50
11895-H02H-100
50 µg 
100 µg 
Add to Cart
  • Slide 1
発現宿主: Human Cells  
51060-M02H-50
51060-M02H-100
50 µg 
100 µg 
Add to Cart
  • Slide 1
発現宿主: Human Cells  
81142-R05H-50
81142-R05H-100
50 µg 
100 µg 
Add to Cart
  • Slide 1
製品の説明:   
発現宿主: Human Cells  
90250-C02H-50
90250-C02H-100
50 µg 
100 µg 
Add to Cart
  • Slide 1

Browse BTLA/CD272 Products by

BTLA/CD272 Related Area

BTLA/CD272 関連経路

    BTLA/CD272 サマリー & タンパク質情報

    BTLA/CD272 背景

    遺伝子の概要: BTLA gene encodes a member of the immunoglobulin superfamily. The encoded protein contains a single immunoglobulin (Ig) domain and is a receptor that relays inhibitory signals to suppress the immune response. Alternative splicing results in multiple transcript variants. Polymorphisms in BTLA gene have been associated with an increased risk of rheumatoid arthritis. [provided by RefSeq, Aug 2011]
    General information above from NCBI
    サブユニット構造: Interacts with tyrosine phosphatases PTPN6/SHP-1 and PTPN11/SHP-2. Interacts with TNFRSF14/HVEM. {ECO:0000269|PubMed:12796776, ECO:0000269|PubMed:14652006, ECO:0000269|PubMed:15568026, ECO:0000269|PubMed:16169851}.
    細胞内位置: Membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.
    翻訳後: Phosphorylated on Tyr residues by TNFRSF14 and by antigen receptors cross-linking, both inducing association with PTPN6 and PTPN11. {ECO:0000269|PubMed:15568026}.; N-glycosylated. {ECO:0000269|PubMed:12796776}.
    シーケンスの類似性: Contains 1 Ig-like V-type (immunoglobulin-like) domain. {ECO:0000305}.
    General information above from UniProt

    BTLA is a inhibitory molecule which belongs to the Ig superfamily. It down-modulates immune responses. As such, reagents that regulate the binding of BTLA to its ligand or alter BTLA signaling have significant therapeutic promise. BTLA is crucial to understand the mechanism(s) of action of these antibodies before attempting clinical applications. BTLA is not expressed by naive T cells, but it is induced during activation and remains expressed on T helper type 1 (T(H)1) but not T(H)2 cells. BTLA is a third inhibitory receptor on T lymphocytes with similarities to cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and programmed death 1 (PD-1).

    Immune Checkpoint
    Immune Checkpoint Targets   Co-inhibitory Immune Checkpoint Targets

    Immunotherapy   Cancer Immunotherapy   Targeted Therapy

    BTLA/CD272 代替名

    BTLA1,CD272, [homo-sapiens]
    B and T lymphocyte attenuator,B- and T-lymphocyte attenuator,B- and T-lymphocyte-associated protein,BTLA1,CD272, [human]
    A630002H24,B and T lymphocyte attenuator,B- and T-lymphocyte attenuator,B- and T-lymphocyte-associated protein, [mouse]
    A630002H24, [mus-musculus]

    BTLA/CD272 関連研究

  • Fourcade J, et al. (2012) CD8(+) T cells specific for tumor antigens can be rendered dysfunctional by the tumor microenvironment through upregulation of the inhibitory receptors BTLA and PD-1. Cancer Res. 72(4):887-96.
  • Kojima R, et al. (2011) Molecular basis for herpesvirus entry mediator recognition by the human immune inhibitory receptor CD160 and its relationship to the cosignaling molecules BTLA and LIGHT. J Mol Biol. 413(4):762-72.
  • Oki M, et al. (2011) A functional polymorphism in B and T lymphocyte attenuator is associated with susceptibility to rheumatoid arthritis. Clin Dev Immunol. 305656.
  • 注意:すべての製品は、"研究目的のみに使用するものであり、診断または治療目的に使用するものではありません"